SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-18-017408
Filing Date
2018-09-25
Accepted
2018-09-25 09:55:53
Documents
15
Period of Report
2018-09-25
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K oxfd20180924_8k.htm 8-K 28804
2 EXHIBIT 2.1 ex_124528.htm EX-2.1 962543
3 EXHIBIT 99.1 ex_124530.htm EX-99.1 15093
4 EXHIBIT 99.2 ex_124529.htm EX-99.2 5419
5 a09.jpg GRAPHIC 78766
6 a2z2.jpg GRAPHIC 81293
7 a1z1.jpg GRAPHIC 116695
8 a06.jpg GRAPHIC 58712
9 a05.jpg GRAPHIC 118310
10 a04.jpg GRAPHIC 76262
11 a03.jpg GRAPHIC 106634
12 a02.jpg GRAPHIC 212703
13 a01.jpg GRAPHIC 87834
14 a2a.jpg GRAPHIC 4340
15 a1a.jpg GRAPHIC 5555
  Complete submission text file 0001437749-18-017408.txt   2318503
Mailing Address 94C INNOVATION DRIVE MILTON PARK ABINGDON X0 OX14 4RZ
Business Address 94C INNOVATION DRIVE MILTON PARK ABINGDON X0 OX14 4RZ 44 01235 442780
Oxford Immunotec Global PLC (Filer) CIK: 0001586049 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36200 | Film No.: 181084921
SIC: 2835 In Vitro & In Vivo Diagnostic Substances